Gessica Sala

Research interests

Publications

• NMR-driven identification of anti-amyloidogenic compounds in green and roasted coffee extracts

  Food Chemistry · 2018 · 10.1016/j.foodchem.2018.01.075

• Inhibition of retrograde transport modulates misfolded protein accumulation and clearance in motoneuron diseases

  Autophagy · 2017 · 10.1080/15548627.2017.1308985

• Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro : A new possible toxic mechanism contributing to Parkinson’s disease

  NeuroToxicology · 2016 · 10.1016/j.neuro.2016.04.018

• Role of Chaperone-Mediated Autophagy Dysfunctions in the Pathogenesis of Parkinson’s Disease

  Frontiers in Molecular Neuroscience · 2016 · 10.3389/fnmol.2016.00157

• Rotenone Upregulates Alpha-Synuclein and Myocyte Enhancer Factor 2D Independently from Lysosomal Degradation Inhibition

  BioMed Research International · 2013 · 10.1155/2013/846725

• Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset

  Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2013 · 10.3109/21678421.2013.851247

• Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease

  Brain Research · 2013 · 10.1016/j.brainres.2013.12.017

• Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia

  Neuropharmacology · 2011 · 10.1016/j.neuropharm.2011.01.003

• Post-Traumatic Stress Disorder

  Journal · 2010 · 10.1007/978-3-540-68706-1_1482

• Pervasive Developmental Disorders

  Journal · 2010 · 10.1007/978-3-540-68706-1_503

• Passive Avoidance

  Journal · 2010 · 10.1007/978-3-540-68706-1_160

• Progressive-Ratio Schedule

  Journal · 2010 · 10.1007/978-3-540-68706-1_1236

• Vesicular monoamine transporter 2 mRNA levels are reduced in platelets from patients with Parkinson’s disease

  Journal of Neural Transmission · 2010 · 10.1007/s00702-010-0446-z

• Memorial Delirium Assessment Scale

  Journal · 2010 · 10.1007/978-3-540-68706-1_1159

• Pathological Gambling

  Journal · 2010 · 10.1007/978-3-540-68706-1_349

• Protein Kinase Inhibitors

  Journal · 2010 · 10.1007/978-3-540-68706-1_3498

• Psychomotor Stimulants

  Journal · 2010 · 10.1007/978-3-540-68706-1_3504

• Brain Stimulation Reward

  Journal · 2010 · 10.1007/978-3-540-68706-1_1309

• Prenatal Exposure to Alcohol

  Journal · 2010 · 10.1007/978-3-540-68706-1_1341

• Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures.

  Neurobiology of Disease · 2006 · 10.1016/j.nbd.2006.07.016

• Increased Susceptibility to Plasma Lipid Peroxidation in Alzheimer Disease Patients

  Current Alzheimer Research · 2004 · 10.2174/1567205043332171

• Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis

  Neurochemistry International · 2004 · 10.1016/j.neuint.2004.10.002

• Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer’s disease

  Neurobiology of Aging · 2003 · 10.1016/s0197-4580(03)00085-x

• Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine

  Neurobiology of Disease · 2003 · 10.1016/s0969-9961(03)00043-3

• Peripheral cytokine release in Alzheimer patients: correlation with disease severity

  Neurobiology of Aging · 2003 · 10.1016/s0197-4580(03)00010-1

• Decreased platelet glutamate uptake and genetic risk factors in patients with Parkinson's disease

  Neurological Sciences · 2001 · 10.1007/s100720170049

• Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis

  Neurology · 2001 · 10.1212/wnl.56.2.270

• Reduced platelet glutamate uptake in Parkinson's disease

  Journal of Neural Transmission · 1999 · 10.1007/s007020050189

Current projects

No projects listed.